201 related articles for article (PubMed ID: 2643486)
1. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
[TBL] [Abstract][Full Text] [Related]
2. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar.
Clonfero E; Zordan M; Cottica D; Venier P; Pozzoli L; Cardin EL; Sarto F; Levis AG
Carcinogenesis; 1986 May; 7(5):819-23. PubMed ID: 3698208
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
Clonfero E; Zordan M; Venier P; Paleologo M; Levis AG; Cottica D; Pozzoli L; Jongeneelen FJ; Bos RP; Anzion RB
Int Arch Occup Environ Health; 1989; 61(6):363-8. PubMed ID: 2744865
[TBL] [Abstract][Full Text] [Related]
4. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons.
Granella M; Clonfero E
Mutat Res; 1992 Jul; 268(1):131-7. PubMed ID: 1378179
[TBL] [Abstract][Full Text] [Related]
7. [Mutagenic effects of coal tar used in the treatment of psoriasis].
Gardosová D; Mezencevová V; Kalina I; Hejj F; Kopka M; Petrovicová J
Bratisl Lek Listy; 1997 Mar; 98(3):146-9. PubMed ID: 9264819
[TBL] [Abstract][Full Text] [Related]
8. Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation.
Borska L; Smejkalova J; Cerna M; Hamakova K; Kucera I; Kremlacek J; Pelikanova D; Fiala Z
Mutat Res; 2010 Feb; 696(2):144-7. PubMed ID: 20096371
[TBL] [Abstract][Full Text] [Related]
9. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar.
Gabbani G; Pavanello S; Nardini B; Tognato O; Bordin A; Fornasa CV; Bezze G; Clonfero E
Mutat Res; 1999 Mar; 440(1):27-33. PubMed ID: 10095126
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of workers exposed to coal tar pitch volatiles in an anode plant.
Venier P; Clonfero E; Cottica D; Gava C; Zordan M; Pozzoli L; Levis AG
Carcinogenesis; 1985 May; 6(5):749-52. PubMed ID: 4006058
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light.
Wheeler LA; Saperstein MD; Lowe NJ
J Invest Dermatol; 1981 Aug; 77(2):181-5. PubMed ID: 7276613
[TBL] [Abstract][Full Text] [Related]
12. [The urinary mutagenicity test in monitoring exposure to aromatic polycyclic hydrocarbons in workers in the aluminum industry].
Granella M; Venier P; Zordan M; Clonfero E
Med Lav; 1992; 83(5):511-8. PubMed ID: 1297066
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
Hansen AM; Poulsen OM; Menné T
Acta Derm Venereol; 1993 Jun; 73(3):188-90. PubMed ID: 8105615
[TBL] [Abstract][Full Text] [Related]
14. Genotoxic effect of Goeckerman regimen of psoriasis.
Fiala Z; Borska L; Pastorkova A; Kremlacek J; Cerna M; Smejkalova J; Hamakova K
Arch Dermatol Res; 2006 Oct; 298(5):243-51. PubMed ID: 16902768
[TBL] [Abstract][Full Text] [Related]
15. [Mutagenic activity of urine of patients with psoriasis treated with pharmaceutical black coal tar].
Gardosová D; Kalina I; Hejj F; Mezencevová V; Salagovic J; Némethová G
Cas Lek Cesk; 1994 Aug; 133(15):463-6. PubMed ID: 8082111
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between PAH content and mutagenic activity of fumes from roofing and paving asphalts and coal tar pitch.
Machado ML; Beatty PW; Fetzer JC; Glickman AH; McGinnis EL
Fundam Appl Toxicol; 1993 Nov; 21(4):492-9. PubMed ID: 8253302
[TBL] [Abstract][Full Text] [Related]
17. [The mutagenic activity of coal tar].
Lycheva TA; Khitrovo IA; Kosoĭ GKh; Khesina AIa; Belitskiĭ GA
Eksp Onkol; 1990; 12(2):17-20. PubMed ID: 2180675
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity studies with urine concentrates from coke plant workers.
Møller M; Dybing E
Scand J Work Environ Health; 1980 Sep; 6(3):216-20. PubMed ID: 7010246
[TBL] [Abstract][Full Text] [Related]
19. Fluoranthene, a volatile mutagenic compound, present in creosote and coal tar.
Bos RP; Prinsen WJ; van Rooy JG; Jongeneelen FJ; Theuws JL; Henderson PT
Mutat Res; 1987 Mar; 187(3):119-25. PubMed ID: 3547111
[TBL] [Abstract][Full Text] [Related]
20. Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process.
Borska L; Andrys C; Krejsek J; Palicka V; Vorisek V; Hamakova K; Kremlacek J; Borsky P; Fiala Z
J Dermatol Sci; 2016 Mar; 81(3):192-202. PubMed ID: 26748978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
